• Ideaya Biosciences chief accounting officer sells $382,130 in stock By Investing.com Investing.com Canada Thu, 09 Jul 2026 21:07:53 GMT
• Form 4 Ideaya Biosciences Inc For: 9 July By Investing.com Investing.com Canada Thu, 09 Jul 2026 21:07:34 GMT
• IDEAYA Biosciences (IDYA) CAO exercises options, sells 9,550 pre-planned shares Stock Titan Thu, 09 Jul 2026 20:57:18 GMT
• How Ideaya Biosciences Inc. (IDYA) Affects Rotational Strategy Timing Stock Traders Daily Wed, 08 Jul 2026 02:54:01 GMT
• IDEAYA Biosciences (IDYA) Joins Russell Growth Benchmarks, Is The Stock Fully Priced? simplywall.st Wed, 08 Jul 2026 01:51:21 GMT
• Form 144 IDEAYA Biosciences For: 7 July By Investing.com Investing.com India Tue, 07 Jul 2026 21:30:56 GMT
• Truist Financial Maintains IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $63 Moomoo Tue, 07 Jul 2026 19:23:28 GMT
• RBC Capital Adjusts IDEAYA Biosciences Price Target to $48 From $53, Maintains Outperform Rating Moomoo Tue, 07 Jul 2026 13:26:09 GMT
• How Investors Are Reacting To IDEAYA Biosciences (IDYA) Broad Russell Growth Index Inclusion simplywall.st Fri, 03 Jul 2026 07:54:39 GMT
• AI Drug Discovery Stocks Retail Investors Are Watching After Claude Science simplywall.st Wed, 01 Jul 2026 00:32:32 GMT
• IDEAYA Biosciences, Inc.(NasdaqGS:IDYA) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Mon, 29 Jun 2026 21:07:30 GMT
• IDEAYA Biosciences, Inc.(NasdaqGS: IDYA) added to Russell 2000 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 10:58:17 GMT
• Enterprise value to EBIT forward of IDEAYA Biosciences, Inc. – NASDAQ:IDYA TradingView Mon, 29 Jun 2026 03:37:43 GMT
• Enterprise value to EBITDA forward of IDEAYA Biosciences, Inc. – NASDAQ:IDYA TradingView Mon, 29 Jun 2026 03:28:48 GMT
• Enterprise value to revenue forward of IDEAYA Biosciences, Inc. – NASDAQ:IDYA TradingView Mon, 29 Jun 2026 00:42:34 GMT
• Price to book forward of IDEAYA Biosciences, Inc. – NASDAQ:IDYA TradingView Sun, 28 Jun 2026 22:35:45 GMT
• Price to earnings forward of IDEAYA Biosciences, Inc. – NASDAQ:IDYA TradingView Sun, 28 Jun 2026 16:36:39 GMT
• IDEAYA Biosciences, Inc.(NasdaqGS: IDYA) added to Russell 3000 Growth Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire Fri, 26 Jun 2026 10:00:00 GMT
• Press Release: IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Moomoo Fri, 26 Jun 2026 10:00:00 GMT
• ideaya biosciences, inc. actuals & estimates (nasdaq:idya) TradingView Fri, 26 Jun 2026 05:11:50 GMT
• IDEAYA Biosciences (IDYA) First Patient Enrollment Puts Valuation Back In Focus simplywall.st Thu, 25 Jun 2026 07:00:00 GMT
• ideaya biosciences surges on promising results for hard-to-treat melanoma MSN Wed, 24 Jun 2026 09:53:37 GMT
• Shareholders back IDEAYA (NASDAQ: IDYA) proposals as board names new chair Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• ideaya biosciences inc (idya) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• IDEAYA Biosciences (IDYA) Is Up 13.2% After New MTAP Trial And Roche Collaboration - Has The Bull Case Changed? Sahm Mon, 22 Jun 2026 07:00:00 GMT
• ideaya biosciences inc (idya) financial health: profitability & balance sheet analysis TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• ideaya biosciences stock - weekly outlook after muted technicals AD HOC NEWS Sat, 20 Jun 2026 16:06:27 GMT
• ideaya biosciences inc (idya) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 10:28:06 GMT
• ideaya biosciences inc (idya) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 08:56:15 GMT
• IDEAYA Biosciences (IDYA) director receives stock options on 20,000 shares Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• IDEAYA (IDYA) director Terry Rosen receives 20,000 stock options at $30.57 Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Director at IDEAYA Biosciences (IDYA) receives 20,000-share stock option grant Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• IDEAYA (IDYA) director receives grant of 20,000 stock options Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• IDEAYA (IDYA) director Scott Morrison receives grant of 20,000 stock options Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• ideaya biosciences (idya) director awarded stock options on 20,000 shares Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• ideaya biosciences inc (idya) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 03:28:25 GMT
• ideaya biosciences inc (idya) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 02:23:38 GMT
• ideaya biosciences inc (idya) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 02:19:23 GMT
• ideaya biosciences, inc. announces yujiro s. hata elected as chairman of board of directors marketscreener.com Wed, 17 Jun 2026 11:05:47 GMT
• IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors PR Newswire Wed, 17 Jun 2026 07:00:00 GMT
• cancer research ceo yujiro hata now also chairs ideaya board Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: cadrenal therapeutics, inc. (cvkd) and ideaya biosciences (idya) The Globe and Mail Wed, 17 Jun 2026 07:00:00 GMT
• ideaya biosciences (idya) stock could be 81.5% below fair value after trial milestone simplywall.st Wed, 17 Jun 2026 05:32:39 GMT
• ideaya biosciences inc (idya) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 02:47:08 GMT
• mizuho securities maintains ideaya biosciences(idya.us) with buy rating, maintains target price $50 Moomoo Tue, 16 Jun 2026 07:00:00 GMT
• why is ideaya biosciences stock rallying today? by investing.com Investing.com Nigeria Mon, 15 Jun 2026 14:45:05 GMT
• ideaya biosciences enrolls first patient in ide892 phase 1/2 trial grafa.com Mon, 15 Jun 2026 14:31:00 GMT
• ideaya begins trial of ide892 combo in lung, pancreatic cancer Investing.com Mon, 15 Jun 2026 10:27:47 GMT
• ideaya biosciences, inc. (idya) latest stock news & headlines Yahoo Finance Mon, 15 Jun 2026 10:13:44 GMT
• IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Com... PR Newswire Mon, 15 Jun 2026 07:00:00 GMT
• New drug combo targets MTAP-deleted pancreatic and lung cancers Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• lifesci capital maintains ideaya biosciences(idya.us) with buy rating, maintains target price $62 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• is ideaya biosciences (idya) quietly reframing its mtap strategy with the new ide892 combinations? Sahm Mon, 15 Jun 2026 07:00:00 GMT
• ideaya biosciences stock rises on phase 1/2 cancer trial start Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• wedbush maintains ideaya biosciences(idya.us) with buy rating, maintains target price $58 Moomoo Fri, 12 Jun 2026 12:34:00 GMT
• ideaya biosciences, inc. (idya) reports q1 loss, misses revenue estimates MSN Thu, 11 Jun 2026 21:49:27 GMT
• ideaya biosciences, inc. (idya) latest stock news & headlines Yahoo Finance Thu, 11 Jun 2026 21:38:01 GMT
• Ideaya Biosciences (IDYA) Forms Clinical Partnership With Roche for IDE892 Efficacy Study Yahoo Finance Thu, 11 Jun 2026 07:00:00 GMT
• IDEAYA Biosciences: 'Strong Buy' On Darovasertib NDA Filing Submission Completion H2 2026 Seeking Alpha Thu, 11 Jun 2026 07:00:00 GMT
• Ideaya Biosciences Stock Crashes 10% Despite Citizens Reiterating Highly Bullish Price Target on Oncology Pipeline TIKR.com Thu, 11 Jun 2026 07:00:00 GMT
• ideaya biosciences prices $300m public offering of shares and pre-funded warrants at $27/share MSN Wed, 10 Jun 2026 23:59:47 GMT
• ideaya biosciences closes $345m public offering by investing.com Investing.com South Africa Wed, 10 Jun 2026 22:24:00 GMT
• ideaya biosciences closes $345 million public offering marketscreener.com Wed, 10 Jun 2026 20:32:15 GMT
• IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire Wed, 10 Jun 2026 07:00:00 GMT
• IDEAYA Biosciences raises $323.6M in follow-on offering of common stock and pre-funded warrants TradingView Wed, 10 Jun 2026 07:00:00 GMT
• ideaya biosciences (nasdaq: idya) raises $323.6m via stock and pre-funded warrants Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• update: ideaya shares fall after pricing $300 million offering Moomoo Tue, 09 Jun 2026 18:40:39 GMT
• ubs maintains ideaya biosciences(idya.us) with buy rating, maintains target price $50 Moomoo Tue, 09 Jun 2026 10:34:00 GMT
• Latham Watkins Advises IDEAYA Biosciences on Offering of Common Stock and Pre Funded Warrants Latham & Watkins LLP Tue, 09 Jun 2026 07:00:00 GMT
• Peninsula company lines up $345 million stock deal targeting eye cancer The Business Journals Tue, 09 Jun 2026 07:00:00 GMT
• citizens reiterates ideaya biosciences stock rating on asco data Investing.com Tue, 09 Jun 2026 07:00:00 GMT
• mission produce posts downbeat q2 earnings, joins ideaya biosciences, perrigo and other big stocks moving Benzinga Tue, 09 Jun 2026 07:00:00 GMT
• ideaya biosciences prices $300 million stock offering by investing.com Investing.com South Africa Tue, 09 Jun 2026 07:00:00 GMT
• ideaya (nasdaq: idya) raises ~$281m via 5.56m shares and pre-funded warrants Stock Titan Tue, 09 Jun 2026 07:00:00 GMT
• ideaya biosciences prices $300m public offering of common stock and pre-funded warrants Pluang Tue, 09 Jun 2026 02:55:54 GMT
• ideaya sets $27 price in $300m stock and warrant sale to investors Stock Titan Tue, 09 Jun 2026 02:25:34 GMT
• ideaya announces pricing of $300 million offering of common stock and pre-funded warrants PR Newswire Tue, 09 Jun 2026 02:22:00 GMT
• IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants PR Newswire Mon, 08 Jun 2026 07:00:00 GMT
• Ideaya Biosciences stock falls on $300M stock offering plan Investing.com Mon, 08 Jun 2026 07:00:00 GMT
• ideaya announces proposed public offering of common stock and pre-funded warrants PR Newswire Mon, 08 Jun 2026 07:00:00 GMT
• ideaya biosciences plans up to $300m stock, warrant sale, plus $45m option Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• ideaya sets $27 price in $300m stock and warrant sale to investors Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• ideaya (nasdaq: idya) seeks $300m in stock and pre-funded warrants, $45m option Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• ideaya biosciences announced plans for a public offering, expecting to raise up to 300 million dollars. Bitget Mon, 08 Jun 2026 05:09:04 GMT
• assessing ideaya biosciences (idya) valuation after roche collaboration and darovasertib trial progress simplywall.st Sun, 07 Jun 2026 07:00:00 GMT
• is darovasertib data and roche pact reshaping the investment case for ideaya biosciences (idya)? Sahm Sat, 06 Jun 2026 18:35:11 GMT
• What IDEAYA Biosciences (IDYA)'s Darovasertib Phase 2/3 Win and Roche Deal Mean For Shareholders Yahoo Finance Sat, 06 Jun 2026 07:00:00 GMT
• is darovasertib data and roche pact reshaping the investment case for ideaya biosciences (idya)? simplywall.st Fri, 05 Jun 2026 16:48:52 GMT
• ideaya (idya) chief development officer reports 297,200-share stock option holding Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• cantor fitzgerald reiterates ideaya biosciences stock rating Investing.com UK Thu, 04 Jun 2026 09:15:02 GMT
• ideaya biosciences announces clinical collaboration with roche i GuruFocus Thu, 04 Jun 2026 07:50:36 GMT
• goldman sachs maintains ideaya biosciences(idya.us) with hold rating, raises target price to $36 Moomoo Thu, 04 Jun 2026 07:00:00 GMT
• ideaya partners with roche on pancreatic cancer drug trial Investing.com UK Thu, 04 Jun 2026 06:06:03 GMT
• mizuho securities maintains ideaya biosciences(idya.us) with buy rating, maintains target price $50 Moomoo Wed, 03 Jun 2026 16:31:03 GMT
• lifesci capital maintains ideaya biosciences(idya.us) with buy rating, maintains target price $62 Moomoo Wed, 03 Jun 2026 14:32:00 GMT
• ideaya biosciences, inc. 8-k filing details for june 3, 2026: company information, nasdaq listing, and sec compliance Minichart Wed, 03 Jun 2026 10:34:00 GMT
• IDEAYA Biosciences Announces Clinical Collaboration with Roche in MTAP-Deleted RAS-Mutant Pancreatic Cancer PR Newswire Wed, 03 Jun 2026 07:00:00 GMT
• With billions of dollars at stake, trio of Bay Area biotechs nail down deals The Business Journals Wed, 03 Jun 2026 07:00:00 GMT
• roche, ideaya test new drug combo for pancreatic cancers lacking targeted drugs Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• ideaya to work with roche on combo pancreatic cancer treatment Seeking Alpha Wed, 03 Jun 2026 07:00:00 GMT
• cantor fitzgerald reiterates ideaya biosciences stock rating Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• ideaya biosciences (idya) teams with roche on ide892 and pan‑ras combo in mtap‑deleted pancreatic cancer Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• ideaya partners with roche on pancreatic cancer drug trial Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• ideaya biosciences (idya) jefferies global healthcare conference 2026 summary Quartr Wed, 03 Jun 2026 07:00:00 GMT
• guggenheim maintains ideaya biosciences(idya.us) with buy rating, maintains target price $54 Moomoo Wed, 03 Jun 2026 00:11:29 GMT
• truist financial maintains ideaya biosciences(idya.us) with buy rating Moomoo Tue, 02 Jun 2026 12:31:00 GMT
• guggenheim maintains ideaya biosciences(idya.us) with buy rating, maintains target price $54 富途牛牛 Tue, 02 Jun 2026 12:31:00 GMT
• wedbush maintains ideaya biosciences(idya.us) with buy rating, maintains target price $58 富途牛牛 Tue, 02 Jun 2026 12:31:00 GMT
• citizens reiterates ideaya biosciences stock rating on trial data Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• news flash: analysts just made a substantial upgrade to their ideaya biosciences, inc. (nasdaq:idya) forecasts Sahm Tue, 02 Jun 2026 07:00:00 GMT
• ideaya highlights positive phase 2/3 darovasertib trial results TipRanks Mon, 01 Jun 2026 21:00:47 GMT
• ideaya and servier present complete phase 2/3 melanoma data grafa.com Mon, 01 Jun 2026 19:10:00 GMT
• ideaya’s darovasertib combo shows improved survival in melanoma trial Investing.com Mon, 01 Jun 2026 15:07:46 GMT
• IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combinatio... PR Newswire Mon, 01 Jun 2026 07:00:00 GMT
• drug combo helps uveal melanoma patients with no approved options go longer without progression Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• darovasertib combo boosts uveal melanoma outcomes in ideaya (idya) phase 2/3 trial Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• ideaya holds steady heading into asco—traders watch for next mover on idya Bez Kabli Sun, 31 May 2026 13:44:41 GMT
• ideaya biosciences spotlights darovasertib win, fda review path at oncology summit MSN Fri, 29 May 2026 22:54:19 GMT
• biotech ideaya grants new hires 221,000 options over 4 years Stock Titan Fri, 29 May 2026 07:00:00 GMT
• ideaya biosciences announces inducement grants under nasdaq listing rule 5635(c)(4) PR Newswire Fri, 29 May 2026 07:00:00 GMT
• j.p. morgan maintains ideaya biosciences(idya.us) with buy rating, cuts target price to $66 Moomoo Fri, 29 May 2026 07:00:00 GMT
• ideaya biosciences spotlights darovasertib win, fda review path at oncology summit MSN Wed, 27 May 2026 05:06:09 GMT
• IDEAYA Biosciences Announces Participation at the 2026 Jefferies Global Healthcare Conference PR Newswire Tue, 26 May 2026 07:00:00 GMT
• how ideaya’s darovasertib nda push and commercial buildout at ideaya biosciences (idya) has changed its investment story simplywall.st Tue, 26 May 2026 07:00:00 GMT
• ideaya biosciences says melanoma drug on track for nda after strong trial data MSN Mon, 25 May 2026 16:50:24 GMT
• ideaya biosciences eyes busy 2026 as darovasertib advances toward fda filing Yahoo Finance Mon, 25 May 2026 07:00:00 GMT
IDEAYA Biosciences, Inc(NASDAQ:IDYA) 
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate is IDE196, a protein kinase C inhibitor that is...
Website: http://www.ideayabio.com
Founded: 2015
IPO Price: $10 (May 23, 2019)
Full Time Employees: 58
CEO: Yujiro S. Hata
Sector: Healthcare
Industry: Biotechnology